HROW
HROW
US4158581094
Harrow, Inc.
Loading chart...

Company Profile

-

Related stocks

PCRX
PCRX • United States
Pacira BioSciences, Inc.
36.31 USD
1.45B USD 1Y +55.4%
IRWD
IRWD • United States
Ironwood Pharmaceuticals, Inc.
3.82 USD
631.22M USD 1Y +144.9%
PAHC
PAHC • United States
Phibro Animal Health Corporatio
38.3 USD
1.56B USD 1Y +0.8%
ANIP
ANIP • United States
ANI Pharmaceuticals, Inc.
73.89 USD
1.7B USD 1Y -21.5%
PBH
PBH • United States
Prestige Consumer Healthcare In
48.23 USD
2.28B USD 1Y -24.4%
AMPH
AMPH • United States
Amphastar Pharmaceuticals, Inc.
26.62 USD
1.13B USD 1Y -0.7%
BCRX
BCRX • United States
BioCryst Pharmaceuticals, Inc.
8.55 USD
2.18B USD 1Y +13.9%
COLL
COLL • United States
Collegium Pharmaceutical, Inc.
22.09 USD
719.15M USD 1Y -33.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
69.6% p.a.
Max Drawdown (5Y)
-71.2%
Sharpe Ratio (5Y)
0.34
Beta Factor
0.18
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 2026%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (69.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.2% in the extended horizon.
ende